PL434014A1 - Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole - Google Patents

Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole

Info

Publication number
PL434014A1
PL434014A1 PL434014A PL43401420A PL434014A1 PL 434014 A1 PL434014 A1 PL 434014A1 PL 434014 A PL434014 A PL 434014A PL 43401420 A PL43401420 A PL 43401420A PL 434014 A1 PL434014 A1 PL 434014A1
Authority
PL
Poland
Prior art keywords
novel
fluorene derivatives
pharmaceutically acceptable
acceptable salts
fluorene
Prior art date
Application number
PL434014A
Other languages
English (en)
Other versions
PL243516B1 (pl
Inventor
Dawid PANEK
Barbara MALAWSKA
Anna PASIEKA
Jakub JOŃCZYK
Anna WIĘCKOWSKA
Justyna GODYŃ
Natalia SZAŁAJ
Marek BAJDA
Kinga SAŁAT
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL434014A priority Critical patent/PL243516B1/pl
Priority to US17/907,152 priority patent/US12492163B2/en
Priority to PCT/PL2021/050033 priority patent/WO2021235956A2/en
Priority to EP21745463.6A priority patent/EP4153561B1/en
Publication of PL434014A1 publication Critical patent/PL434014A1/pl
Publication of PL243516B1 publication Critical patent/PL243516B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest grupa nowych pochodnych 9H-fluorenu nadających się do wytwarzania substancji czynnych przeznaczonych do leczenia choroby Alzheimera, zwłaszcza jako wielofunkcyjnych inhibitorów enzymów BuChE, BACE1 oraz agregacji beta-amyloidu.
PL434014A 2020-05-20 2020-05-20 Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole PL243516B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL434014A PL243516B1 (pl) 2020-05-20 2020-05-20 Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole
US17/907,152 US12492163B2 (en) 2020-05-20 2021-05-20 9H-fluorene derivatives or their pharmaceutically acceptable salts
PCT/PL2021/050033 WO2021235956A2 (en) 2020-05-20 2021-05-20 Novel 9h-fluorene derivatives or their pharmaceutically acceptable salts
EP21745463.6A EP4153561B1 (en) 2020-05-20 2021-05-20 9h-fluoren derivates or their pharmaceutically acceptable salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434014A PL243516B1 (pl) 2020-05-20 2020-05-20 Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole

Publications (2)

Publication Number Publication Date
PL434014A1 true PL434014A1 (pl) 2021-11-22
PL243516B1 PL243516B1 (pl) 2023-09-04

Family

ID=77022165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434014A PL243516B1 (pl) 2020-05-20 2020-05-20 Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole

Country Status (4)

Country Link
US (1) US12492163B2 (pl)
EP (1) EP4153561B1 (pl)
PL (1) PL243516B1 (pl)
WO (1) WO2021235956A2 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27967A1 (es) 2002-09-10 2004-05-31 Pfizer Acetil 2-hindroxi-1,3-diaminoalcanos
CA2558034A1 (en) * 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors
US20210347727A1 (en) * 2017-06-23 2021-11-11 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof

Also Published As

Publication number Publication date
US12492163B2 (en) 2025-12-09
US20230117233A1 (en) 2023-04-20
PL243516B1 (pl) 2023-09-04
EP4153561B1 (en) 2026-04-29
WO2021235956A3 (en) 2022-02-03
WO2021235956A2 (en) 2021-11-25
EP4153561A2 (en) 2023-03-29

Similar Documents

Publication Publication Date Title
PH12020500265A1 (en) Indole carboxamides compounds useful as kinase inhibitors
PH12020551578A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
ZA202403388B (en) Small molecules for treatement of cancer
JOP20230277A1 (ar) مثبطات الكرومينون الألستيرية للفوسفونوسيتيد 3-كيناز (pi3k) لعلاج الأمراض
MX2022013647A (es) Imidazopiridazinas como moduladores de il-17.
CL2023001367A1 (es) Inhibidores de btk
ECSP034567A (es) Inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas
BR112023016590A2 (pt) Inibidores de tyk2 e seus usos
BR112014031730A2 (pt) entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1
ATE369861T1 (de) Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
CO2022001482A2 (es) Formas cristalinas de 7-cloro-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamida
TN2013000393A1 (fr) Derives de la pyrazolospirocetone pour une utilisation comme inhibiteurs de l'acetyl-coa carboxylase
JOP20240237A1 (ar) مركبات أريل غير متجانسة لمعالجة الألم
EA201291413A1 (ru) Производные 3-амино-5,6-дигидро-1h-пиразин-2-она, применимые для лечения болезни альцгеймера и других форм деменции
MX2020010033A (es) Moduladores calpaina y usos terapeuticos de los mismos.
CR20220382A (es) Derivados de carboxamida heteroaromática como inhibidores de la calicreína plasmática
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
MA28170A1 (fr) Nouveaux derives de ceto-oxadiazole comme inhibiteurs de la cathepsine
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
WO2021242844A8 (en) Grk2 inhibitors and uses thereof
ATE506941T1 (de) Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon
IS2214B (is) Meðhöndlun á mígreni með því að gefa inn alfa-lípósýru eða afleiður hennar
SA523440809B1 (ar) مشتقات سيكلو بنتا ثيوفين كربوكساميد كمضادات مستقبل عامل تنشيط الصفائح الدموية